Views 480
Citations 0
In This Issue of JAMA
August 9, 2016


Author Affiliations

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;316(6):563-565. doi:10.1001/jama.2015.14419

Cerebral emboli are a common risk of transcatheter aortic valve implantation (TAVI). In a clinical trial involving 100 patients with severe aortic stenosis who were randomly assigned to undergo TAVI with or without a cerebral embolism protection (filter) device, Haussig and colleagues found that use of the protection device reduced the frequency of ischemic lesions. In an Editorial, Messé and Mack discuss interventions to improve cerebral safety of high-risk cardiovascular procedures.

First Page Preview View Large
First page PDF preview
First page PDF preview